Can a respiratory #virus infection confer #immunity against the other #respiratory virus? A much-debated issue in the virus immunology for many decades. What is the probable immune mechanism & does it indeed exist? What is the evidence for & against this hypothesis? 1/
It is hypothesized that a respiratory virus infection confers immunity against the same and other respiratory viruses for a short time, perhaps a few weeks. This immunologic mechanism, known as #heterosubtypic ‘temporary non-specific immunity’ 2/
This immune protection is associated with activation of the innate immune response to viral infection mediated by the release of Type I #interferons (IFN) & other cytokines that have broad protective effects against a range of viruses 3/
Besides, viruses are known to interfere with the circulation of other viruses. For example, there is evidence that the circulation of #Rhinovirus in the community interferes & decreases the spread of seasonal & pandemic #influenza viruses 4/

pubmed.ncbi.nlm.nih.gov/19822124/
Last year, me & @dr_puneet wrote a piece for @EditorIndPed on the similar theme 5/

pubmed.ncbi.nlm.nih.gov/32525495/
Now, a recent study by the @YaleMed have reignited this debate. The researchers find that exposure to the #rhinovirus, the most frequent cause of the common cold, can protect against infection by the #SARSCoV2 virus @Yale @VirusesImmunity 6/

rupress.org/jem/article/21…
The study demonstrates that prior infection with a #rhinovirus protects against the replication of SARSCoV2 as a result of the intact antiviral response that was already present at the time of the infection by SARS-CoV-2 7/
pubmed.ncbi.nlm.nih.gov/34128960/
#SARSCoV2 #RNA increases exponentially, with a doubling time of ∼6 h, and infection induces a robust ISG response in organoids by day 4 after infection 8/
the researchers infected airway epithelial organoid cultures with human rhinovirus and evaluated the effect that this virus had on the expression of #ACE2. Following the rhinovirus infection, the truncated form of ACE2 known as dACE2 was found to increase significantly 9/
In a 2nd study, they infected the same type of organoid cultures with #SARSCoV2, w/ or w/out a prior infection by the #rhinovirus. Three days after the initial infection, rhinovirus-infected cells were found to induce the expression of #ISGs 10/
Comparatively, SARS-CoV-2 infected organoids that were not previously exposed to rhinovirus experienced a dramatic increase in their viral load 11/
Furthermore, SARS-CoV-2 infected organoid cultures that were previously infected with rhinovirus exhibited a significant increase in IFN1 levels as compared to organoid cultures that were not previously infected with the rhinovirus 12/
At early parts in the infection, pre infected cultures were found to exhibit a greater expression of ISGs as compared to organoids that were not previously infected with the rhinovirus 13/
They found that at the start of infection with #SARSCoV2, the viral #RNA replicates at an exponential rate that induces #ISG expression levels....... 14/
......When previously infected by the #rhinovirus, the induction of #ISG expression is much more rapid, thereby allowing the innate immune system to inhibit SARSCoV2 replication more quickly 15/
Overall, the studies performed by them demonstrate that prior infection with a #rhinovirus protects against the replication of #SARSCoV2 as a result of the intact antiviral response that was already present at the time of the infection by SARS-CoV-2 16/
This graphic summarizes the key messages. Heterologous innate immunity creates a subset of individuals refractory to infection during periods of high respiratory virus circulation....... 17/
A. Virus 1 induces mucosal #IFN, which creates a refractory period following infection during which ISGs are elevated & the host is protected from a 2nd viral infection (red shading). After ISGs return to baseline, the host is again susceptible & can be infected with virus 2
18/
(B) During periods of high resp virus circulation, a fraction of the population is refractory to infection at any given time due to ISG activation from a recent infection (red shaded figures) 19/
Thus, heterologous innate immune protection could mitigate against viral transmission at times of high respiratory virus circulation 20/
There are hidden interactions between viruses that we don’t quite understand, and the above findings are a piece of the puzzle we are just now looking at! @Yale @YaleMed @florian_krammer @trvrb @profvrr 21/end

news.yale.edu/2021/06/15/com…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vipin M. Vashishtha

Vipin M. Vashishtha Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @vipintukur

19 Jun
#Spike protein’ is the major target of #NAbs in infected/vaccinated people. The prefusion conformation of the Spike represents the most relevant target because Abs can successfully interfere w/ infection only if they prevent binding to target cells or prevent fusion itself 1/
Various approaches are adopted to express ‘#Spike’ protein in vivo, such as nucleic acid structures & virus vectors. Alternatively, other vaccine platforms like recombinant protein particles & inactivated vaccines can directly deliver this protein 2/
Most structural studies of the wild-type spike protein exhibited one #RBD in the 'open' conformation. By contrast, 2 or 3 RBDs were observed in the open conformation in the more infective #D614G mutant--the RBD #conformation plays a vital role in the infectivity of SARSCoV2 3/
Read 16 tweets
17 Jun
Developing an #mRNA vaccine is a sure-shot way to success? No! Despite the spectacular performance of #Pfizer & #Moderna vaccines, we also have a #CureVac fiasco. We need to dig in much deeper into the intricacies of developing a highly efficacious mRNA vaccine 1/
There is more than low dose & impact of VOCs behind #CureVac’s failure. And here we once again need to salute the sheer brilliance of @kkariko . Will do a little thread to explain, why! 2/
No doubt, the #CureVac used a much lower #RNA dose. Dose is lower (12 (CureVac) vs 30 (#Pfizer) vs 100 ug (#Moderna)) but no idea how that translates to protein. Need to know how much of a role the lower dose played in the lower efficacy 3/
Read 20 tweets
14 Jun
In the #US & #Mexico trial of #Novavax vaccine (where 50% were #Alfa variant), it shows an overall efficacy of 90.4% & 100% efficacy against moderate or severe disease, on par with the vaccines made by Pfizer-BioNTech and Moderna nytimes.com/2021/06/14/hea…
“Novavax may be used as a booster in the U.S., but it’s certainly will be the first vaccine a lot of people are going to see around the world”
#Novavax new booster vax against #Beta variant is also found highly immunogenic in #baboon studies. A strong anamnestic response was demonstrated in baboons boosted with rS-B.1.351 approximately one year after immunization with #NVXCoV2373 (rS-WU1)

biorxiv.org/content/10.110…
Read 6 tweets
14 Jun
#DELTA DIARY: It is clear we are now dealing with a virus that spreads far more easily - probably more than twice as easily - as the version that emerged in #Wuhan at the end of 2019 1/

science.thewire.in/health/face-wi…
The #Ro was around 2.5 when the pandemic started in Wuhan and could be as high as 8.0 for the Delta variant 2/
DELTA is evolving: A new, more genetically diverse cluster, lineage AY.1 (which is termed as #Delta+) with a new spike substitution #N417K having immune escape property, has emerged independently in some countries @vinodscaria 3/
Read 9 tweets
13 Jun
After almost 6 months of global rollout of #Covid19 vaccines, we have some data to assess their comparative efficacy/effectiveness. There seems to be a gradient in their performances:
*Best performing: BNT162b2 (Israel, US & UK) & Moderna’s mRNA & Sputnik-V (Bahrain) 1/
*Moderately effective: #AstraZeneca (UK), #JNJ (US, data still evolving)
*Modestly effective: #Sinovac’s CoronaVac (Chile, Brazil, Uruguay, Middle East) #Sinopharm’s inactivated (Seychelles, Mongolia) 2/
But on safety front, the #inactivated vaccines have scored over all others, both on reactogenicity front & as far as rare, serious AEFIs are concerned 3/
Read 5 tweets
5 Jun
What does #HerdImmunity mean in context with #SARSCoV2?
We don’t need the entire population to be vaccinated or the vaccines to be 100% effective (they never are); we just need them to reduce infection rates enough to get us <1. That is herd immunity 1/

wsj.com/articles/the-c…
The issue is more complex. Despite achieving high seropositivity in certain regions, resurgences have occurred. And in certain regions/countries, the virus suddenly retracted even in the absence of a significant sero-positivity 2/
It is not a pure mathematics. There is an interplay of infection or vaccine-induced immunity & the evolution in the virus. The 'Ro' is not a fixed number--keep on changing with the virus transmissibility. With this changes the thresholds to achieve 3/
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(